Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 28.1 DKK 2.93% Market Closed
Market Cap: 12B DKK

Intrinsic Value

The intrinsic value of one EMBLA stock under the Base Case scenario is 38.1 DKK. Compared to the current market price of 28.1 DKK, Embla Medical hf is Undervalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EMBLA Intrinsic Value
38.1 DKK
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Embla Medical hf

EMBLA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for EMBLA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EMBLA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Embla Medical hf
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Embla Medical hf

Current Assets 397m
Cash & Short-Term Investments 87.6m
Receivables 121.9m
Other Current Assets 187.4m
Non-Current Assets 1.1B
Long-Term Investments 23.1m
PP&E 199.6m
Intangibles 873m
Other Non-Current Assets 46.4m
Efficiency

Free Cash Flow Analysis
Embla Medical hf

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Embla Medical hf

Revenue
854.9m USD
Cost of Revenue
-320.2m USD
Gross Profit
534.7m USD
Operating Expenses
-421.5m USD
Operating Income
113.2m USD
Other Expenses
-44.9m USD
Net Income
68.3m USD
Fundamental Scores

EMBLA Profitability Score
Profitability Due Diligence

Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
54/100
Profitability
Score

Embla Medical hf's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

EMBLA Solvency Score
Solvency Due Diligence

Embla Medical hf's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
55/100
Solvency
Score

Embla Medical hf's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EMBLA Price Targets Summary
Embla Medical hf

Wall Street analysts forecast EMBLA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EMBLA is 40.24 DKK with a low forecast of 36.36 DKK and a high forecast of 44.94 DKK.

Lowest
Price Target
36.36 DKK
29% Upside
Average
Price Target
40.24 DKK
43% Upside
Highest
Price Target
44.94 DKK
60% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EMBLA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one EMBLA stock?

The intrinsic value of one EMBLA stock under the Base Case scenario is 38.1 DKK.

Is EMBLA stock undervalued or overvalued?

Compared to the current market price of 28.1 DKK, Embla Medical hf is Undervalued by 26%.

Back to Top